Cancer remains the dominant disease target for biotech through to 2010.
| Autor: | Pijpers, Fleur1 fpijpers@datamonitor.com, Belsey, Mark J.2 |
|---|---|
| Zdroj: | Journal of Commercial Biotechnology. Jul2006, Vol. 12 Issue 4, p294-298. 5p. 2 Graphs. |
| Databáze: | Business Source Ultimate |
| Externí odkaz: |
|